Analysts predict significant upside for select stocks, with potential returns ranging from 13% to 43%. Divi’s Laboratories is poised to benefit from its involvement in diabetes and weight loss drugs. Devyani International’s acquisition of Sky Gate Hospitality is expected to boost its QSR business, while Anant Raj’s data center plans drive its growth despite revised timelines.
Negative Breakout: These 9 stocks cross below their 200 DMAs
In the Nifty500 pack, nine stocks’ closing prices crossed below their 200-day moving averages (DMA) on September 21, according to technical scan data from StockEdge.